According to a new market research report "EMO Machine Market
by Modality (Veno-Arterial (VA), Veno-Venous (VV), Arterio-Venous
(AV)), Application (Respiratory, Cardiac, Extracorporeal Cardiopulmonary
Resuscitation (ECPR)), and Region - Analysis & Forecasts to 2021"
published by MarketsandMarkets, The market is expected to reach USD
305.3 Million by 2021 from USD 247.2 Million in 2016, at a CAGR of 4.3%.
Browse
78 market data Tables and 31 Figures spread through 129 Pages and
in-depth TOC on "Extracorporeal Membrane Oxygenation Machine Market"
Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=255167654
The
report analyzes and studies the major market drivers,
restraints/challenges, and opportunities for the forecast period of 2016
to 2021. A number of factors such as the growing cardiovascular and
respiratory diseases, rising adoption of ECMO as a bridge to heart &
lung transplantation, growing number of ECMO centers, conferences and
training programs to increase awareness, and technological advancements
are the significant factors driving the growth of this Extracorporeal
Membrane Oxygenation Machine Market. In addition, the growing aging
population and the number of people suffering from cardiopulmonary
diseases in populous countries such as India and China are factors that
are expected to offer significant growth opportunities for ECMO systems.
However, complications associated with ECMO such as bleeding,
infections, and technical failures; along with high cost and lack of
skilled professionals is a challenge to the market.
The global
ECMO machine market is segmented on the basis of modality, applications,
and regions. Based on the modality, the global market is segmented into
venoarterial (VA), venovenous (VV), and arteriovenous (AV). The
venovenous (VV) segment is estimated to account for the largest share of
the global market in 2016, and venoarterial (VA) segment is projected
to grow at the highest CAGR in the forecast period.
Based on
application, the global Extracorporeal Membrane Oxygenation Machine
Market is segmented into Respiratory, Cardiac, and Extracorporeal
Cardiopulmonary Resuscitation (ECPR). The respiratory segment is
estimated to account for the largest share of the market in 2016. The
large share of this segment can be attributed to factors such as rising
incidence of respiratory failure, lung cancer, and lung transplants, and
increasing adoption of ECMO.
On the basis of region, the global
ECMO machine market is divided into North America, Europe, Asia-Pacific,
and the Rest of the World (RoW). In 2016, North America accounted for
the largest share of the market, followed by Europe, Asia-Pacific, and
the Rest of the World. The Asia-Pacific market is projected to grow at
the highest CAGR and serve as a revenue pocket for companies offering
ECMO systems.
Request For Sample Pages: http://www.marketsandmarkets.com/requestsample.asp?id=255167654
In
2015, the market was dominated by the Getinge Group (Sweden), Medtronic
plc (Ireland), and LivaNova PLC (U.K.). These companies together
contributed about 68.8% to the global market in 2015. The other players
in the Extracorporeal Membrane Oxygenation Machine Market are XENIOS AG
(Germany), Terumo Corporation (Japan), MicroPort Scientific Corporation
(China), NIPRO Corporation (Japan), OriGen Biomedical, Inc. (U.S.),
ALung Technologies, Inc. (Germany), and EUROSETS S.r.l. (Italy).
About MarketsandMarkets™
MarketsandMarkets™
provides quantified B2B research on 30,000 high growth niche
opportunities/threats which will impact 70% to 80% of worldwide
companies' revenues. Currently servicing 7500 customers worldwide
including 80% of global Fortune 1000 companies as clients. Almost 75,000
top officers across eight industries worldwide approach
MarketsandMarkets™ for their painpoints around revenues decisions.
Our
850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global
high growth markets following the "Growth Engagement Model – GEM". The
GEM aims at proactive collaboration with the clients to identify new
opportunities, identify most important customers, write "Attack, avoid
and defend" strategies, identify sources of incremental revenues for
both the company and its competitors. MarketsandMarkets™ now coming up
with 1,500 MicroQuadrants (Positioning top players across leaders,
emerging companies, innovators, strategic players) annually in high
growth emerging segments. MarketsandMarkets™ is determined to benefit
more than 10,000 companies this year for their revenue planning and help
them take their innovations/disruptions early to the market by
providing them research ahead of the curve.
MarketsandMarkets's
flagship competitive intelligence and market research platform,
"Knowledge Store" connects over 200,000 markets and entire value chains
for deeper understanding of the unmet insights along with market sizing
and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/extracorporeal-membrane-oxygenation-systems.asp
No comments:
Post a Comment